Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/22364
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMladenović, Tamara-
dc.contributor.authorZivic, Fatima-
dc.contributor.authorPetrovic, Nenad-
dc.contributor.authorNjezic, Sasa-
dc.contributor.authorPavic, Jelena-
dc.contributor.authorKotorčević, Nikola-
dc.contributor.authorMilenković, Strahinja-
dc.contributor.authorGrujovic, Nenad-
dc.date.accessioned2025-06-12T08:58:09Z-
dc.date.available2025-06-12T08:58:09Z-
dc.date.issued2024-
dc.identifier.issn1996-1944en_US
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/22364-
dc.description.abstractThis paper reviews the latest trends and applications of silicone in ophthalmology, especially related to intraocular lenses (IOLs). Silicone, or siloxane elastomer, as a synthetic polymer, has excellent biocompatibility, high chemical inertness, and hydrophobicity, enabling wide biomedical applications. The physicochemical properties of silicone are reviewed. A review of methods for mechanical and in vivo characterization of IOLs is presented as a prospective research area, since there are only a few available technologies, even though these properties are vital to ensure medical safety and suitability for clinical use, especially if long-term function is considered. IOLs represent permanent implants to replace the natural lens or for correcting vision, with the first commercial foldable lens made of silicone. Biological aspects of posterior capsular opacification have been reviewed, including the effects of the implanted silicone IOL. However, certain issues with silicone IOLs are still challenging and some conditions can prevent its application in all patients. The latest trends in nanotechnology solutions have been reviewed. Surface modifications of silicone IOLs are an efficient approach to further improve biocompatibility or to enable drug-eluting function. Different surface modifications, including coatings, can provide long-term treatments for various medical conditions or medical diagnoses through the incorporation of sensory functions. It is essential that IOL optical characteristics remain unchanged in case of drug incorporation and the application of nanoparticles can enable it. However, clinical trials related to these advanced technologies are still missing, thus preventing their clinical applications at this moment.en_US
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.relation.ispartofMaterials (Basel, Switzerland)en_US
dc.titleApplication of Silicone in Ophthalmology: A Reviewen_US
dc.typearticleen_US
dc.identifier.doi10.3390/ma17143454en_US
Appears in Collections:Faculty of Engineering, Kragujevac

Page views(s)

36

Downloads(s)

1

Files in This Item:
File Description SizeFormat 
materials-17-03454.pdf1.83 MBAdobe PDFThumbnail
View/Open


Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.